홈/주식/ELAN

ELAN

USD

Elanco Animal Health Incorporated Common Stock

$22.500+0.270 (1.215%)

실시간 가격

Healthcare

Drug Manufacturers - Specialty & Generic

미국

가격 차트

Loading Chart...

핵심 지표

시장 지표

기업 기본 정보

거래 통계

시장 지표

시가

$22.230

고가

$22.840

저가

$22.150

거래량

12.80M

기업 기본 정보

시가총액

11.2B

산업

Drug Manufacturers - Specialty & Generic

국가

United States

거래 통계

평균 거래량

7.18M

거래소

NYQ

통화

USD

52주 범위

저가 $8.02현재가 $22.500고가 $22.96

관련 뉴스

2025년 10월 27일 · 오전 10:27

PR Newswire

Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

Elanco Animal Health Incorporated (NYSE: ELAN) today announced label expansions for two of its leading canine prescription parasiticides, Credelio...

Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

2025년 10월 24일 · 오후 08:55

PR Newswire

Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...

Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

2025년 10월 7일 · 오전 10:08

Analyst Upgrades

JP Morgan Upgrades Elanco Animal Health to Overweight, Raises Price Target to $24

JP Morgan analyst Chris Schott upgrades Elanco Animal Health from Neutral to Overweight and raises the price target from $18 to $24.

JP Morgan Upgrades Elanco Animal Health to Overweight, Raises Price Target to $24

ELAN

가격 차트